Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema

Objective: To assess the effectiveness, safety, and treatment burden in eyes with persistent diabetic macular edema (DME) for up to 1 year after administration of 0.19 mg fluocinolone acetonide (FAc) implant (Iluvien(®)). Methods: This retrospective study at one private practice in the US included 4...

Descripción completa

Detalles Bibliográficos
Autor principal: Coney, Joseph M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549741/
https://www.ncbi.nlm.nih.gov/pubmed/31213929
http://dx.doi.org/10.2147/IMCRJ.S192524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549741/
https://www.ncbi.nlm.nih.gov/pubmed/31213929
http://dx.doi.org/10.2147/IMCRJ.S192524

Ejemplares similares